Resources

This poster, designed for vaccine providers, outlines that some children aged 6 months to under 5 years who are at higher risk of severe illness from COVID-19 may be eligible for the COVID-19 vaccine.

This evaluation report was completed by KPMG as a first step in the urgent review of the Aged Care Quality Standards.

This data file contains statistical data about Australia's COVID-19 vaccinations.

This document summarises the discussion and outcomes of the first Digital Transformation Sector Partners meeting on 5 August 2022

This document summarises the discussion and outcomes of the first Digital Transformation Sector Partners meeting on 19 August 2022.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 5 September 2022.

This presentation, delivered on 6 September 2022, contains an update to Australia's COVID-19 vaccine rollout.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 2 September 2022.

Health Ministers met on 2 September 2022 and discussed concerns regarding cosmetic surgery, especially the risks to consumers.

This presentation, delivered on 5 September 2022, contains an update to Australia's COVID-19 vaccine rollout.

This data file contains statistical data about Australia's COVID-19 vaccinations.

These reports list the percentage of people who have been vaccinated against COVID-19 by local government area (LGA).

This document summarises the discussion and outcomes of the first Digital Transformation Sector Partners meeting on 2 September 2022.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 1 September 2022.

This presentation, delivered on 2 September 2022, contains an update to Australia's COVID-19 vaccine rollout.

This data file contains statistical data about Australia's COVID-19 vaccinations.

This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, testing and PPE provided to affected services.

This declaration from the Minister for Health and Aged Care is a reporting requirement under Section 34A of the Tobacco Advertising Prohibition Act 1992.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 31 August 2022.

This presentation, delivered on 1 September 2022, contains an update to Australia's COVID-19 vaccine rollout.

This data file contains statistical data about Australia's COVID-19 vaccinations.

Summary of the consideration of the application from Sanofi Pty Ltd for the inclusion of avalglucosidase alfa (Nexviazyme®) on the Life Saving Drugs Program (LSDP) for the treatment of Pompe Disease.

This report outlines the Elosulfase alfa 24 Month Review Terms of Reference and Protocol Questions

Facilities that handle security sensitive biological agents (SSBAs) can use this template to help them make sure they identify and manage all risks associated with handing SSBAs. Use of the template is not mandatory.

This tool helps entities and facilities that handle security sensitive biological agents (SSBAs) to check their compliance with the SSBA Standards. Use of this tool is not mandatory.